Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Alcohol Drinking

• Experimental Study on Alcohol Use and Behavior in Young Adults
• Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
• Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
• Internalized Stress in Relation to Alcohol Consumption
• Ketamine for Combined Depression and Alcohol Use Disorder
• The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
• Effect of Nutritional Ketosis on Alcohol Metabolism
• Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 1
• Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder
• Intranasal Insulin for Treatment of Alcohol Use Disorder
• MDMA for AUD/PTSD Comorbidity
• Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
• Randomized, Controlled Trial of Rybelsus (Semaglutide) Among Adults With Alcohol Use Disorder (AUD)
• Imaging Inflammation With Alcohol Use Disorder: an [18F]NOS Study
• Citicoline in Youth Alcohol Use Disorder
• Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation in Patients With Severe Alcohol Use Disorder: a Phase ii Trial
• Emergency Department-Initiated Medications for Alcohol Use Disorder
• Social Effects of Alcohol
• Spironolactone in Alcohol Use Disorder (SAUD)
• Pregnenolone for the Treatment of Alcohol Use Disorder
• Cytisine for Smoking Cessation
• A Randomised, Controlled Trial of MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
• Towards a Wearable Alcohol Biosensor: Examining the Accuracy of BAC Estimates From New-Generation Transdermal Technology Using Large-Scale Human Testing and Machine Learning Algorithms
• Testing a Novel Therapeutic Strategy for Comorbid Post-Traumatic Stress Disorder and Alcohol Use Disorder
• An Open-Label, Single Dose Study in Patients With Alcohol Use Disorder
• Ketamine for the Treatment for Alcohol Use Disorder in the ED
• Orexin Receptor Antagonists as Modulators of Threat Sensitivity in Individuals With Alcohol Use Disorder
• Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)
• Alcohol Use Disorder and Cannabidiol
• Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease
• Semaglutide for Alcohol Use Disorder
• LSD Treatment for Persons With Alcohol Use Disorder
• Psilocybin-assisted Psychotherapy for Treatment of Alcohol Use Disorder
• Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
• A Randomized, Double-blind Placebo-Controlled Study of Ibudilast for Treating Alcohol Use Disorder
• A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
• Cannabis' Impact on Alcohol Consumption
• Enhancing the Effects of Adolescent Alcohol Treatment With Acetyl-L-Carnitine
• Cannabidiol in Youth Alcohol Use Disorder
• Does Oxytocin Alter Tolerance to or Motivation for Alcohol
• Dexamethasone to Target Stress and Immune System Mechanisms Underlying Alcohol Craving
• Utility of Brexanolone to Target Stress-induced Alcohol Use Among Men and Women With Posttraumatic Stress Disorder
• LGG Supplementation in Patients With AUD and ALD
• Cannabidiol for Reducing Drinking in Alcohol Use Disorder
• The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
• Human Laboratory Study of ASP8062 for Alcohol Use Disorder
• Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder
• In Hospital IM Naltrexone: A Pilot Study
• Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
• Alcoholic Liver Disease and the Gut Microbiome
• A Study of NAC for AUD
• Neural and Hormonal Influences on Sex Differences in Risk for AUD
• Neuroimaging Mechanisms by Which Memory and Glucocorticoids Promote Risky Drinking
• CBD for the Treatment of Alcohol Use Disorder
• Opioid Modulation and Neural Reward Activation in Healthy Adults
• Novel mGluR5 Modulator Effects on Alcohol Drinking and MRI Outcomes
• Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study
• ED Initiated Oral Naltrexone for AUD
• Enhancing the Effects of Alcohol Treatment With Lamotrigine
• Research on Translational Outcomes of Alcohol (Project RETRO)
• Role of BP1.3656 on Alcohol Responses
• Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
• Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
• Ketone Ester Intervention in Alcohol Use Disorder
• Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
• Estradiol Effects on Alcohol Across the Menstrual Cycle
• CBT-I Augmentation of TOP for Sobriety and Insomnia in AUD
• Inpatient Single Dose Interventions for Alcohol Use Disorder
• Effect of Endotoxin on Alcohol Consumption
• Oxytocin to Enhance Integrated Treatment for AUD and PTSD
• Vortioxetine for Treatment of Depressive Mood and Alcohol Use
• Feasibility Trial of Pregnenolone for Posttraumatic Stress Disorder and Alcohol Use Disorder
• Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
• Laboratory Screening of Lorcaserin for Alcohol Use Disorder
• ANCHORS Alcohol & Sexual Health Study: UH3 Project
• Pregabalin Trial for the Treatment of Alcohol Use Disorder
• Development of a Selective ALDH2 Inhibitor to Treat AUD
• Alcohol and Opioids
• Measuring the Neuroimmune Response to Alcohol
• A Novel Human Lab Model for Screening AUD Medications
• Probenecid as Medication for Alcohol Use Disorder
• Neuroimmune Dysfunction in Alcohol Use Disorder
• Varenicline and Bupropion for Alcohol Use Disorder
• Imaging Glutamate Release From Alcohol
• Bristol Imperial MDMA in Alcoholism Study
• MAP4343 Treatment for Alcohol Use Disorder
• Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
• Alpha-1 Blockade for Alcohol Use Disorder (AUD)
• Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects
• Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
• Feasibility of Emergency Department Initiated Extended-Release Naltrexone for the Treatment of Alcohol Use Disorder
• Alcohol and Cigarette Craving During Oxytocin Treatment
• Brexpiprazole in Alcohol Use Disorder
• HLAB-002 of ANS-6637 for Alcohol Use Disorder
• Behavior Brain Responses
• Alcohol, Behavior, and Brain Imaging
• Cannabidiol for Alcohol Use Disorder
• COMT Inhibition Among Individuals With Comorbid AUD/ADHD
• Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD)
• Suvorexant in the Management Comorbid Sleep Disorder and Alcohol Dependence
• Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder
• Intranasal Oxytocin for the Treatment of Alcohol Use Disorder
• The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders
• Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
• [C-11]PiB PET Imaging in Alcohol Use Disorders
• Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
• Addressing Heavy Alcohol Use Consumption With Kudzu
• N-Acetylcysteine for Adolescent Alcohol Use Disorder
• Marijuana Effects on Simulated Driving Performance
• Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
• Oxytocin Treatment for Alcohol Use Disorders
• Hangover and Residual Zopiclone Effect on Spatial Perception
• Oxytocin and Stress Response in Alcohol Use Disorder
• Ibudilast for the Treatment of Alcohol Use Disorder
• Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking?
• Behavioral Effects of Drugs: Inpatient (36) (Alcohol, Duloxetine, and Methylphenidate)
• Effects of THC and Alcohol on Driving Performance
• Exploration of Gemfibrozil as a Treatment for AUD
• Ibudilast and Withdrawal-Related Dysphoria
• Alcohol and Immune Response
• Behavioral Alcohol Responses (BAR) Study
• Understanding Alcohol Reward in Social Context
• [C-11]NOP-1A and Alcohol Use Disorder
• Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment
• Modafinil for the Treatment of Alcohol Use Disorders
• Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder
• Zonisamide Outpatient Study
• Acute Neuroimmune Effects of Alcohol Using Free Water Imaging
• Alcohol and Implicit Process in Sexual Risk Behavior in MSM
• Mavoglurant in Alcohol Drinking
• Alcohol Use and Mental Health - Pilot Test of Video-assisted Drinking Topography
• The Alcohol-Pain Connection: Mechanisms and Genetic/Psychological Correlates
• Nicotinic Receptor Genetic Variation and Alcohol Reward
• St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
• Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers
• Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.
• Pregabalin as Treatment for Alcohol Use Disorder
• Effects of Cannabidiol in Alcohol Use Disorder
• Cannabidiol as a Treatment for AUD Comorbid With PTSD
• Minocycline for Alcohol Use Disorder
• Neuroscience-Informed Treatment Development for Adolescent Alcohol Use
• Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
• Influence of n-Acetylcysteine Maintenance on Alcohol Effects
• Topiramate and Prolonged Exposure
• Over-arousal as a Mechanism Between Alcohol and Intimate Partner Violence
• Human Laboratory Study of Varenicline for Alcohol Use Disorder
• Nalmefene, Baclofen and Impulsivity in Subjects With Alcohol Use Disorder and Healthy Control Subjects
• Topiramate Treatment of Alcohol Use Disorders in African Americans
• Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking
• Reduced Nicotine Cigarettes in Smokers With and Without Alcohol Use Disorder
• Marijuana's Impact on Alcohol Motivation and Consumption
• Clinical Trial for Alcohol Use Disorder and Post Traumatic Stress Disorder (PTSD)
• Saracatinib and Alcohol Drinking
• Aripiprazole for Bipolar Disorder and Alcohol Use Disorder
• Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
• Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
• Varenicline Augmentation of Patch Outcomes in Heavy Drinkers' Smoking Cessation
• Studying Partial-agonists for Ethanol and Tobacco Elimination in Russians With HIV (St PETER HIV)
• N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI
• Nalmefene in Alcohol Dependence and Borderline Personality Disorder
• Effects of Tolcapone on Decision Making and Alcohol Intake in Alcohol Users
• Neural Mechanisms of Disulfiram Effects
• Investigating the Interactions of AZD0530 With Alcohol in Social Drinkers
• Effect of Heavy Alcohol Consumption on Farnesoid X Receptor (FXR) Signaling
• Ketamine for Reduction of Alcoholic Relapse
• Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
• Title: Effect of Opioid Receptor Modulation on Alcohol Self-Administration and Neural Response to Alcohol Cues in Heavy Drinkers: Role of OPRM1 Gene Variation
• Phone-based Safety Monitoring of Baclofen Prescriptions for Alcohol Use Disorder
• Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders
• A Dose-Escalation Study to Determine the Maximum Tolerated Dose of Arbaclofen Placarbil in Subjects With Alcohol Use Disorder
• CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
• CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders
• Effects of Varenicline in Heavy Drinking Smokers
• Alcohol Disorder hOsPital Treatment Trial
• Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
• Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users
• Effectiveness of Zonisamide in Alcohol Dependent Veterans
• A Multicenter, Randomized, Double-blind, Placebo-controlled, 3-parallel-group Comparison Trial to Investigate the Effect of Nalmefene on Alcohol Consumption Reduction in Patients With Alcohol Dependence (Phase 3 Trial)
• Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder
• Prazosin and Naltrexone (PaN) Study for Veterans With Alcohol Use Disorders
• HORIZANT (Gabapentin Enacarbil Extended-Release Tablets) for the Treatment of Alcohol Use Disorder
• Mifepristone for the Prevention of Relapses of Alcohol Drinking
• Brain Inflammation and Function in Alcoholism
• Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD
• Paradoxical Excitement Response During Sedation Between Dexmedetomidine and Propofol in Hazardous Alcohol Drinker
• Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
• Mifepristone Treatment of Alcohol Use Disorder
• Does Guanfacine Attenuate Stress-Induced Drinking?
• A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
• New Approaches to Smoking Cessation in Heavy Drinkers
• Ondansetron for Bipolar Disorder and Alcohol Use Disorders
• Topiramate's Effects on Heavy Drinking
• Development of Ivermectin for Alcohol Use Disorders
• A Novel Compound for Alcoholism Treatment
• Naltrexone for Individuals of East Asian Descent
• Development of Ibudilast for Alcohol Use Disorder
• Neural Mechanisms of Change During the Treatment of Alcohol Use Disorders With Prazosin
• Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
• Use of Kudzu Extract in the Study of Its Ability to Reduce Alcohol Drinking in Treatment Seeking Alcohol Dependent Persons
• Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers
• Baclofen for Treating Anxiety and Alcoholism
• Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI
• Effects of Topiramate on Adolescent Alcohol Use: Efficacy and Mechanisms
• Role of Proinflammatory Signaling in Alcohol Craving
• Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
• Effects of Inhaled Cannabis on Driving Performance
• ABT-436 for Alcohol Dependence
• Zonisamide for Heavy Drinkers With Bipolar Disorder
• Varenicline Treatment of Alcohol Dependence in Smokers
• Naltrexone and Memantine Effects on Alcohol Drinking Behaviors
• Topiramate for Alcohol Use in Posttraumatic Stress Disorder
• Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
• Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
• A Study on the Biobehavioral Mechanisms of Baclofen and Alcohol Drinking
• Baclofen to Reduce Alcohol Use in Veterans With HCV
• The Role of the Glutamatergic System in the Extinction of Conditioned Reinforcement Processes
• The Effects of Mirtazapine Versus Placebo on Alcohol Consumption in Male Alcohol High Consumers
• Puerarin Effects on Alcohol Drinking
• Does Varenicline Influence Alcohol Consumption in Alcohol Dependent Individuals?
• Do Treatments for Smoking Cessation Affect Alcohol Drinking? Study 1: Nicotine Replacement Therapy
• Varenicline to Reduce Alcohol Consumption in Heavy Drinkers
• Family History Study of Alcohol Consumption Using Memantine
• Topiramate Treatment of Problem Drinkers
• Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans
• Do Treatments for Smoking Cessation Affect Alcohol Drinking?
• Naltrexone for Heavy Drinking in Young Adults
• Quetiapine vs. Placebo in Alcohol Relapse Prevention - a Pilot Study
• Vivitrol for Reducing Driving While Impaired Behavior Among Repeat Offenders
• Medication and Counseling for Controlled Drinking (Project SMART)
• Effects of Therapeutic Doses of Acetaminophen in Moderate Drinkers
• STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
• Targeted Naltrexone for Problem Drinkers
• Effect of Ethanol and Genetic Polymorphisms on Bupropion Metabolism
• Naltrexone Effects on Alcohol Intake
• Effect of Glutathione on Blood Alcohol and Hangover Symptoms
• Rimonabant to Reduce Alcohol Consumption